Genetics Generation Advancement Corp.

Total Valuation

Genetics Generation Advancement Corp. carries a market capitalization of 1.07B, placing it among publicly traded companies globally. Its enterprise value stands at 940.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Genetics Generation Advancement Corp. currently has 26.69M shares outstanding.

Valuation Ratios

Genetics Generation Advancement Corp. trades at a trailing price-to-earnings ratio of 59.35. The price-to-sales ratio is 2.10, and the price-to-book ratio stands at 4.00.

Enterprise Valuation

On an enterprise value basis, Genetics Generation Advancement Corp. trades at an EV/EBITDA multiple of 73.43 and an EV/FCF ratio of 69.76. The EV/Sales ratio of 1.56 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 73.43 provides insight into valuation relative to core operating earnings.

Financial Position

Genetics Generation Advancement Corp. maintains a current ratio of 3.10, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.30, indicating elevated leverage, while an interest coverage ratio of 20.03 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Genetics Generation Advancement Corp. posts a return on equity of 6.37 and a return on invested capital of 1.56.

Taxes

Over the trailing twelve months, Genetics Generation Advancement Corp. has paid 5.96M in income taxes, reflecting an effective tax rate of 21.74.

Stock Price Statistics

Genetics Generation Advancement Corp.'s stock has declined approximately -23.42256% over the past 52 weeks. The 50-day moving average sits at 43.44, while the 200-day moving average is 49.87.

Income Statement

Over the trailing twelve months, Genetics Generation Advancement Corp. generated 603.11M in revenue and converted that into 21.37M in net income, yielding earnings per share of 0.84. EBITDA reached 12.80M, while operating income came in at 12.80M.

Balance Sheet

Genetics Generation Advancement Corp. holds 408.95M in cash and equivalents against 80.08M in total debt, resulting in a net debt position of 5.22M. Total book value stands at 317.28M, with working capital of 418.63M providing operational flexibility.

Cash Flow

Genetics Generation Advancement Corp. produced -18.33M in operating cash flow over the past twelve months. After subtracting -31.31M in capital expenditures, free cash flow totaled -49.64M - equivalent to -1.95 per share.

Margins

Genetics Generation Advancement Corp. operates with a gross margin of 41.52, reflecting its pricing power and cost economics. The operating margin of 2.12 and net profit margin of 3.54 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Genetics Generation Advancement Corp.'s most recent stock split took place on September 19, 2024 with a 20:21 split ratio.

Scores

Genetics Generation Advancement Corp. posts an Altman Z-Score of 5.29, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.